跳至主要内容
临床试验/NCT06159634
NCT06159634招募中不适用

Comparison of the Efficacy of Using a Traction Device in Colonic Endoscopic Submucosal Dissection Versus Conventional ESD: A Randomized Clinical Trial

Baylor College of Medicine2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
Dissection speed

研究概览

简要总结

The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD.

The investigators of this study hypothesize that use of the traction device will help expedite colonic endoscopic submucosal dissections.

详细描述

Endoscopic submucosal dissection (ESD) is the mainstay for the treatment of complex colorectal polyps particularly those with a higher risk of superficial submucosal invasion. However, colonic ESD is technically difficult given the thin colon wall and difficult locations of lesion. Endoscopic submucosal dissection (ESD) of colonic lesions can be difficult because the thins wall of the colon wall and the lack of submucosal space expansion to the degree seen in the submucosal dissection in the esophagus or the stomach. ESD can be done in a standard fashion with circumferential incision followed by submucosal dissection according to gravity, tunneling methods, pocket methods or traction. Traction is frequently used to expedite submucosal dissection in particularly in tough locations or in fibrotic lesions. Traction assisted ESD is particularly attractive in colonic ESD given the above-mentioned difficulties and the challenge with performing other techniques such as tunneling or pocket formation in fibrotic lesions or lesions over folds. Tissue traction can be applied by several methods including gravity, mucosal tension, water pressure, and adjusting the patient's body position. Traction can also be applied using devices such as clip and line, snare or using additional endoscope. Data regarding the value of traction in colonic ESD is controversial. Despite multiple publications about the efficacy of traction devices in the east, there are few published data from the west. The Sure trac system was recently approved in the US for traction assisted ESD. The system has 2 devices, the primary device comes preloaded with a silicone band, while the secondary device features a clip of the same size as the primary device to apply traction on the opposite wall. Traction with sure trac system, is readily assembled and easily accessible and it is equipped with its own clip for swift implementation, thus expediting the process. The purpose of this research is to compare the effectiveness and safety of the sure trac traction system (Micro Tec endoscopy, USA) to standard ESD without applying traction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is ≥ 18 years old.
  • Patients can provide informed consent.
  • Patient is referred for ESD procedure of colonic neoplastic lesions and with one of the following criteria:
  • A- Lesions with prior resection or with scar at any size. B- Granular lateral spreading tumors (GLST) more than 3 cm. C- Non granular lateral spreading tumors (NGLST) more than 20 mm. D- Any suspected submucosal invasion such as Paris classification II a +II or lesions with positive non lifting sign.

排除标准

  • Patient is < 18 years old.
  • Patient refused and/or unable to provide consent.
  • Patient is a pregnant woman.
  • Lesions with morphology: pedunculated type (Paris IP, Ips).
  • Appendiceal orifice or IC valve lesions.
  • Patients with lesions removed with other techniques besides ESD (like hybrid ESD or submucosal tunneling technique STER and EMR).

结局指标

主要结局

Dissection speed

时间窗: Day 1 (procedure day)

Length of time to perform endoscopic submucosal dissection by the operator as measured by calculating area of lesion divided by time (cm\^2/hours).

次要结局

  • Intraprocedural adverse events(Day 1 (procedure day), up to 48 hours after procedure.)
  • Abdominal pain(1 hour post-procedure, 24 hours post-procedure.)
  • En-bloc, R0, and curative resection rates(Day 1 (procedure day))
  • Total procedure time(Day 1 (procedure day))
  • Post-procedural adverse events(1 month post-procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Othman, MD

Principal Investigator

Baylor College of Medicine

研究点 (2)

Loading locations...

相似试验